Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.49 $27,300 - $52,290
21,000 New
21,000 $32,000
Q3 2021

Nov 12, 2021

SELL
$4.83 - $7.2 $104,811 - $156,240
-21,700 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$2.32 - $5.38 $50,344 - $116,746
21,700 New
21,700 $103,000
Q2 2020

Aug 13, 2020

SELL
$1.55 - $2.41 $20,615 - $32,053
-13,300 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$1.32 - $3.77 $4,356 - $12,441
3,300 Added 33.0%
13,300 $23,000
Q4 2019

Feb 12, 2020

BUY
$0.62 - $3.4 $6,200 - $34,000
10,000 New
10,000 $31,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $61.4M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.